AI assistant
Sending…
TG THERAPEUTICS, INC. — Director's Dealing 2021
Jun 23, 2021
31066_dirs_2021-06-22_27ba4586-b156-4096-904f-4ec4167e1dff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2021-06-18
Reporting Person: Charney Laurence N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-18 | COMMON STOCK | A | 20000 | — | Acquired | 180997 | Direct |
| 2021-06-18 | COMMON STOCK | A | 40000 | — | Acquired | 220997 | Direct |
Footnotes
F1: Reflects a grant of restricted shares that will vest on June 18, 2024.
F2: Includes shares of restricted Common Stock, which vest over various time periods.
F3: Reflects a grant of restricted shares that will vest on June 18, 2025.
More from TG THERAPEUTICS, INC.
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 13
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Nov 25
Regulatory Filings
2025
Nov 24